GWM
LMAT icon

Gilpin Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Gilpin Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288 Sell
3
-1
-25% -$103 ﹤0.01% 836
2026
Q1 		$437 Buy
4
+2
+100% +$191 ﹤0.01% 656
2025
Q4 		$163 Buy
+2
New +$172 ﹤0.01% 714

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Gilpin Wealth Management's LMAT Position: Q2 2026 in Review

Gilpin Wealth Management reduced its LeMaitre Vascular (LMAT) stake by 25% in Q2 2026, selling an estimated $103 and leaving 3 shares worth $288. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Gilpin Wealth Management first reported a position in LMAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $437 in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Gilpin Wealth Management held 3 shares of LeMaitre Vascular worth $288 as of Q2 2026.
  • Gilpin Wealth Management sold 1 LeMaitre Vascular share in Q2 2026, an estimated $103.
  • LeMaitre Vascular made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #836 holding.
  • Gilpin Wealth Management first reported a position in LeMaitre Vascular in Q4 2025 and has held it in 3 quarters since.
  • Gilpin Wealth Management's LeMaitre Vascular position peaked at $437 in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.